These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

644 related items for PubMed ID: 9549924

  • 21. A randomised trial comparing cytomegalovirus antigenemia assay vs screening bronchoscopy for the early detection and prevention of disease in allogeneic bone marrow and peripheral blood stem cell transplant recipients.
    Humar A, Lipton J, Welsh S, Moussa G, Messner H, Mazzulli T.
    Bone Marrow Transplant; 2001 Sep; 28(5):485-90. PubMed ID: 11593322
    [Abstract] [Full Text] [Related]

  • 22. Allogeneic hemopoietic stem cell transplantation for patients with high risk acute lymphoblastic leukemia: favorable impact of chronic graft-versus-host disease on survival and relapse.
    Zikos P, Van Lint MT, Lamparelli T, Gualandi F, Occhini D, Bregante S, Berisso G, Mordini N, Incagliato M, Fugazza G, Sessarego M, Bacigalupo A.
    Haematologica; 1998 Oct; 83(10):896-903. PubMed ID: 9830798
    [Abstract] [Full Text] [Related]

  • 23. Some but not all benefits of intravenous immunoglobulin therapy after marrow transplantation appear to correlate with IgG trough levels.
    Cottler-Fox M, Lynch M, Pickle LW, Cahill R, Spitzer TR, Deeg HJ.
    Bone Marrow Transplant; 1991 Jul; 8(1):27-33. PubMed ID: 1655138
    [Abstract] [Full Text] [Related]

  • 24. [Hematopoietic stem cell transplantation for patients with chronic myelogenous leukemia].
    Liu QF, Sun J, Zhang Y, Liu XL, Xu D, Xu B, Feng R, Meng FY, Zhou SY.
    Ai Zheng; 2004 Apr; 23(4):426-9. PubMed ID: 15087032
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Serum cholinesterase is an early and sensitive marker of graft-versus host-disease (GVHD) and transplant-related mortality (TRM).
    Bacigalupo A, Oneto R, Bruno B, Lamparelli T, Gualandi F, Bregante S, Raiola AM, Di Grazia C, Dominietto A, Lombardi A, Frassoni F, Van Lint MT.
    Bone Marrow Transplant; 2001 Dec; 28(11):1041-5. PubMed ID: 11781614
    [Abstract] [Full Text] [Related]

  • 27. [Correlation between human herpesvirus 6 activation and acute graft-versus-host disease after allogeneic hematopoietic stem cell transplantation].
    Wang LR, Dong LJ, Lu DP.
    Zhonghua Xue Ye Xue Za Zhi; 2006 Aug; 27(8):507-10. PubMed ID: 17172120
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Does high-dose intravenous immune globulin treatment after bone marrow transplantation increase mortality in veno-occlusive disease of the liver?
    Klaesson S, Ringdén O, Ljungman P, Aschan J, Hägglund H, Winiarski J.
    Transplantation; 1995 Dec 15; 60(11):1225-30. PubMed ID: 8525515
    [Abstract] [Full Text] [Related]

  • 30. Successful prevention of acute graft-versus-host disease using low-dose antithymocyte globulin after mismatched, unrelated, hematopoietic stem cell transplantation for acute myelogenous leukemia.
    Kim HJ, Min WS, Cho BS, Eom KS, Kim YJ, Min CK, Lee S, Cho SG, Jin JY, Lee JW, Kim CC.
    Biol Blood Marrow Transplant; 2009 Jun 15; 15(6):704-17. PubMed ID: 19450755
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Cytomegalovirus infections in allogeneic stem cell recipients after reduced-intensity or myeloablative conditioning assessed by quantitative PCR and pp65-antigenemia.
    Schetelig J, Oswald O, Steuer N, Radonic A, Thulke S, Held TK, Oertel J, Nitsche A, Siegert W.
    Bone Marrow Transplant; 2003 Oct 15; 32(7):695-701. PubMed ID: 13130317
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34. Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantation.
    Ayuk F, Diyachenko G, Zabelina T, Wolschke C, Fehse B, Bacher U, Erttmann R, Kröger N, Zander AR.
    Biol Blood Marrow Transplant; 2008 Aug 15; 14(8):913-9. PubMed ID: 18640575
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Influence of cytomegalovirus seropositivity on outcome after T cell-depleted bone marrow transplantation: contrasting results between recipients of grafts from related and unrelated donors.
    Meijer E, Dekker AW, Rozenberg-Arska M, Weersink AJ, Verdonck LF.
    Clin Infect Dis; 2002 Sep 15; 35(6):703-12. PubMed ID: 12203168
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Cytomegalovirus shedding in the oral cavity of allogeneic haematopoietic stem cell transplant patients.
    Correia-Silva Jde F, Victória JM, Guimarães AL, Salomão UE, de Abreu MH, Bittencourt H, Gomez RS.
    Oral Dis; 2007 Mar 15; 13(2):163-9. PubMed ID: 17305617
    [Abstract] [Full Text] [Related]

  • 39. Predictors for persistent cytomegalovirus reactivation after T-cell-depleted allogeneic hematopoietic stem cell transplantation.
    Almyroudis NG, Jakubowski A, Jaffe D, Sepkowitz K, Pamer E, O'Reilly RJ, Papanicolaou GA.
    Transpl Infect Dis; 2007 Dec 15; 9(4):286-94. PubMed ID: 17511819
    [Abstract] [Full Text] [Related]

  • 40. CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality.
    Bacigalupo A, Tedone E, Sanna MA, Moro F, Van Lint MT, Grazi G, Balestreri M, Frassoni F, Occhini D, Gualandi F.
    Haematologica; 1992 Dec 15; 77(6):507-13. PubMed ID: 1337746
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.